News
Investing.com -- Barclays warned that margin pressure could loom large over second-quarter U.S. earnings, with rising tariffs ...
Investing.com -- Markets may be inadvertently giving President Donald Trump the green light to escalate tariffs, according to ...
Capricor Therapeutics (NASDAQ:CAPR) stock plunged 53% after the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) rejecting its application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results